Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 pertaining to change in Composition of Committees of the Board

Titan Biotech's board, at its meeting on January 2, 2026, reconstituted four key board committees by inducting two new independent directors – Mr. Brijesh Kumar Singh and Mr. Debendra Kumar Sabat – as members of all of them. The reconstitution covers the Audit Committee, Nomination & Remuneration Committee, Corporate Social Responsibility Committee, and Stakeholders Relationship Committee, all effective January 2, 2026. Existing members and chairpersons (Mr. Rohit Jain, Mrs. Manju Singla, Mr. Abhishek Agarwal, Mr. Naresh Kumar Singla, Mr. Suresh Chand Singla, and Mr. Dhairya Madan) continue in their roles. No members were removed or replaced; this is purely an expansion of committee strength with two new independent directors.